Giorgio Pochetti

Rome, 00015, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.

PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.

Journal: International journal of molecular sciences

Published: October 20, 2021

Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex.

Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex.

Journal: The FEBS journal

Published: August 21, 2021

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 17, 2021

A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities.

A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities.

Journal: Journal of medicinal chemistry

Published: November 03, 2020

Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.

Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 09, 2020

Insights into PPARγ Phosphorylation and Its Inhibition Mechanism.

Insights into PPARγ Phosphorylation and Its Inhibition Mechanism.

Journal: Journal of medicinal chemistry

Published: April 03, 2020

Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination.

Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination.

Journal: Frontiers in chemistry

Published: October 17, 2019

Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation.

Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation.

Journal: Journal of medicinal chemistry

Published: September 11, 2018

Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery.

Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery.

Journal: Methods (San Diego, Calif.)

Published: December 22, 2017

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Journal: Scientific reports

Published: January 23, 2017

Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.

Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: August 25, 2016

Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.

Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.

Journal: Scientific reports

Published: June 02, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026